Cypress Bioscience, Inc. (Cypress) is a pharmaceutical company engaged in providing therapeutics and personalized medicine services and facilitates improved and individual patient care. It primarily focuses on developing therapeutics for the medical condition Fibromyalgia. The company also provides personalized medicine laboratory services which include Avise MCV and Avise PG for rheumatologists. The company received approval for Savella from the FDA in January 2009 for the management of fibromyalgia, a chronic, debilitating disorder affecting up to 6 million Americans. Cypress and Forest Laboratories, jointly market Savella in the US. The company is headquartered in San Diego, the US.

Cypress Bioscience, Inc Key Recent Developments

Aug 10, 2010 Cypress Bioscience Receives Consent For BioLineRx In-License Agreement
Aug 09, 2010 Cypress Reports Net Loss Of $1.8 Million For Q2 2010
May 10, 2010 Cypress Bioscience Reports Net Loss Of $4.6 Million For Q1 2010
Oct 17, 2009 Forest Laboratories, Cypress Report Improvements in Pain, Physical Function By Savella

This comprehensive SWOT profile of Cypress Bioscience, Inc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key
competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered
in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and
efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.